Fred Holubow
CIK 905478 · last filed 2023-06-15
Fred Holubow is a corporate insider who has filed 21 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for TGEN, was dated Jun 15, 2023. Across all open-market trades the lifetime net is −$159.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MEND price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TGEN | Director | — | $1.92 | — | $0 | 3 | 2023-06-15 |
| ANI PHARMACEUTICALS INC (FOLD) Delisted | Director | 14,811 | $14.49 | $214.6K | $0 | 2 | 2018-03-22 |
| ANIP | Director | 16,533 | $72.60 | $1.20M | $0 | 4 | 2016-04-11 |
| ANI PHARMACEUTICALS INC (BPAX) Delisted | Director | 10,210 | — | — | $0 | 6 | 2013-07-16 |
| MICRUS ENDOVASCULAR CORP (MEND) Delisted | Director | 0 | — | — | -$108.7K | 5 | 2010-09-28 |
| ANI PHARMACEUTICALS INC (BPA) Delisted | Director | 62,759 | — | — | -$50.9K | 1 | 2007-05-08 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-15 | TGEN | Grant (A) | — | $0 | EDGAR |
| 2022-06-28 | TGEN | Grant (A) | — | $0 | EDGAR |
| 2020-07-21 | TGEN | Grant (A) | — | $0 | EDGAR |
| 2018-03-22 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Exer (M) | +2,000 | $0 | EDGAR |
| 2017-04-04 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Grant (A) | +1,000 | $0 | EDGAR |
| 2016-04-11 | ANIP | Grant (A) | +1,000 | $0 | EDGAR |
| 2015-04-20 | ANIP | Grant (A) | +800 | $0 | EDGAR |
| 2013-11-04 | ANIP | Grant (A) | +8,310 | $0 | EDGAR |
| 2013-08-05 | ANIP | Grant (A) | — | $0 | EDGAR |
| 2013-07-16 | ANI PHARMACEUTICALS INC (BPAX) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.